Quick Answer
DEXCOM INC reported Gross Profit of $2.80 billion for fiscal year 2025.
DEXCOM INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $2.80B | +14.9% |
| 2024 | $2.44B | +6.5% |
| 2023 | $2.29B | +21.5% |
| 2022 | $1.88B | +12.1% |
| 2021 | $1.68B | +31.3% |
| 2020 | $1.28B | +37.4% |
| 2019 | $931.50M | +40.3% |
| 2018 | $663.90M | +34.9% |
| 2017 | $492.10M | +30.0% |
| 2016 | $378.40M | +35.9% |
| 2015 | $278.40M | +57.9% |
| 2014 | $176.30M | +76.1% |
| 2013 | $100.10M | +114.8% |
| 2012 | $46.60M | +29.8% |
| 2011 | $35.90M | +95.1% |
| 2010 | $18.40M | +402.6% |
| 2009 | $3.66M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $731.40M | +23.2% | +6.2% |
| June 30, 2025 | $688.80M | +9.9% | +16.9% |
| March 31, 2025 | $589.00M | +4.8% | -0.8% |
| September 30, 2024 | $593.80M | -4.7% | -5.2% |
| June 30, 2024 | $626.70M | +14.7% | +11.5% |
| March 31, 2024 | $561.90M | +21.5% | -9.9% |
| September 30, 2023 | $623.30M | +26.1% | +14.1% |
| June 30, 2023 | $546.40M | +21.6% | +18.1% |
- DEXCOM INC showed an increase of +14.9% in Gross Profit compared to the prior fiscal year.
- Over the 2009–2025 period, DEXCOM INC’s gross profit has grown by 76433.7% (from $3.66 million to $2.80 billion).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: